Contrast Enhanced Ultrasound Market to Grow with a CAGR of 4.25% through 2029
Rising prevalence of long-term diseases and comorbidities among the population is expected to drive the Global Contrast Enhanced Ultrasound Market growth in the forecast period, 2025-2029.
According
to TechSci Research report, “Contrast Enhanced Ultrasound Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2029F”, the Global Contrast Enhanced Ultrasound Market stood at USD 1.27 Billion in 2023 and is anticipated to project steady growth in the forecast
period with a CAGR of 4.25% through
2029. Key drivers of market growth include the introduction of cost-effective contrast agents, an increase in ultrasound procedure volumes, and the incorporation of contrast imaging modes as essential features in ultrasound systems. CEUS offers cost efficiency, a radiation-free operation, and enhanced patient comfort compared to other technologies, further promoting market expansion. Integrating CEUS technology into Point-of-Care (PoC) diagnostics has become crucial in addressing COVID-19 challenges. The growing global prevalence of cardiovascular diseases (CVDs), liver and kidney lesions, gastrointestinal disorders, and vascular diseases is expected to boost demand for CEUS services due to their significant clinical benefits in these areas. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, with about 17.9 million deaths annually. The incidence of CVDs is rising, driven by behavioral risk factors like alcohol and tobacco use, sedentary lifestyles, and poor dietary habits.
Several factors are expected to drive market growth over the forecast period, including the rising prevalence of chronic diseases and comorbidities, technological advancements, and increased investments in product development by governments and major corporations. CEUS improves the characterization of focal liver lesions (FLLs), aids in liver cancer detection, guides interventional treatments, and assesses the efficacy of local therapy. Consequently, the growing role of CEUS in liver cancer diagnosis is anticipated to increase demand for CEUS, thereby propelling market growth.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Contrast Enhanced Ultrasound Market”
The Global Contrast Enhanced Ultrasound Market is segmented
into Product, Type, End Use, Regional Distribution, and Company.
Based
on Product, Contrast Agents has emerged as the fastest growing segment in the Global Contrast Enhanced Ultrasound Market in 2023. Ongoing research and development have resulted in the creation of more effective and safer contrast agents, improving imaging quality and making CEUS a more reliable diagnostic tool. As healthcare systems emphasize patient safety and comfort, non-invasive diagnostic methods like CEUS, which utilize contrast agents, are gaining popularity. They provide a safer alternative to imaging modalities that involve radiation. The rising prevalence of chronic conditions such as cardiovascular diseases, liver diseases, and cancer is driving the demand for advanced diagnostic techniques. CEUS, supported by contrast agents, delivers crucial diagnostic information for these conditions. Additionally, contrast agents used in ultrasound are more cost-effective than those used in MRI or CT scans, making CEUS a preferred option for both patients and healthcare providers.
Based
on Region, Asia Pacific have emerged as the fastest growing region in the Global Contrast Enhanced Ultrasound Market in 2023. The region is experiencing an increase in chronic diseases like cancer, cardiovascular conditions, and liver disorders, which is driving the demand for advanced diagnostic imaging techniques such as CEUS. The aging populations in countries like Japan and China further elevate the need for diagnostic imaging services, as older adults are more prone to chronic illnesses. The rapid adoption of advancements in ultrasound technology, including sophisticated contrast agents and enhanced imaging capabilities, is improving the diagnostic accuracy and reliability of CEUS. Additionally, rising healthcare expenditure in the region, fueled by both government initiatives and private sector investments, supports the adoption of advanced medical technologies and services.
Major companies operating in Global Contrast Enhanced
Ultrasound Market are:
·
Lantheus Holdings, Inc.
·
Bracco S.p.A.
·
General Electric Company
·
Siemens Healthineers Company
·
nanoPET Pharma GmbH
·
ESAOTE SPA
·
GE HealthCare Technologies Inc.
·
Koninklijke Philips N.V.
·
Leriva SA
Download Free Sample Report
Customers can also request 10% free customization on this
report
“The projected market growth of contrast enhanced ultrasound is driven by several factors, including the rising prevalence of chronic diseases and comorbidities, technological advancements, and increased investments in product development by governments and major corporations. The surge in research and development (R&D) activities, collaborations, product approvals, and launches is significantly contributing to market expansion. Key market players are employing various business strategies, such as mergers and acquisitions, product launches, joint ventures, and partnerships, to strengthen their position in the global market. Additionally, increasing governmental initiatives aimed at improving healthcare infrastructure in the region are expected to further boost market growth”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Contrast Enhanced Ultrasound Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Equipment, Contrast Agents), By Type (Non-targeted, Targeted), By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers), By Region and Competition, 2019-2029F”, has evaluated the
future growth potential of Global Contrast Enhanced Ultrasound Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Contrast Enhanced Ultrasound Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com